OBJECTIVE: To compare four different inception cohorts of patients with early rheumatoid arthritis (RA) with respect to treatment strategies, disease activity, and outcome during a five year follow up period. METHOD: Data from cohorts of patients with early RA, with a standardised assessment at least every six months for five years from four different centres, were included in one database. Owing to slight differences in the individual study designs, linearly interpolated values were calculated to complete the standard follow up schedule. RESULTS: Despite similar inclusion criteria, significant differences in demographic factors and baseline disease activity were found between the different cohorts. During the follow up an aggressive treatment strategy was followed in the Dutch and Finnish cohort, an intermediate strategy in the British cohort, and a conservative strategy in the Swedish cohort. A significant improvement in disease activity was seen in all cohorts, though the most rapid and striking improvement was seen in those receiving aggressive treatment. This resulted in less radiographic destruction in the long run. CONCLUSION: This observational study of cohorts of patients with early RA confirms that early aggressive treatment results not only in a more rapid reduction of disease activity but also in less radiographic progression in the long term.
OBJECTIVE: To compare four different inception cohorts of patients with early rheumatoid arthritis (RA) with respect to treatment strategies, disease activity, and outcome during a five year follow up period. METHOD: Data from cohorts of patients with early RA, with a standardised assessment at least every six months for five years from four different centres, were included in one database. Owing to slight differences in the individual study designs, linearly interpolated values were calculated to complete the standard follow up schedule. RESULTS: Despite similar inclusion criteria, significant differences in demographic factors and baseline disease activity were found between the different cohorts. During the follow up an aggressive treatment strategy was followed in the Dutch and Finnish cohort, an intermediate strategy in the British cohort, and a conservative strategy in the Swedish cohort. A significant improvement in disease activity was seen in all cohorts, though the most rapid and striking improvement was seen in those receiving aggressive treatment. This resulted in less radiographic destruction in the long run. CONCLUSION: This observational study of cohorts of patients with early RA confirms that early aggressive treatment results not only in a more rapid reduction of disease activity but also in less radiographic progression in the long term.
Authors: D M van der Heijde; M A van 't Hof; P L van Riel; L A Theunisse; E W Lubberts; M A van Leeuwen; M H van Rijswijk; L B van de Putte Journal: Ann Rheum Dis Date: 1990-11 Impact factor: 19.103
Authors: M Dougados; B Combe; A Cantagrel; P Goupille; P Olive; M Schattenkirchner; S Meusser; L Paimela; R Rau; H Zeidler; M Leirisalo-Repo; K Peldan Journal: Ann Rheum Dis Date: 1999-04 Impact factor: 19.103
Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra Journal: Arthritis Rheum Date: 1988-03
Authors: E J Kroot; M A van Leeuwen; M H van Rijswijk; M L Prevoo; M A Van 't Hof; L B van De Putte; P L van Riel Journal: Ann Rheum Dis Date: 2000-12 Impact factor: 19.103
Authors: M A van Leeuwen; D M van der Heijde; M H van Rijswijk; P M Houtman; P L van Riel; L B van de Putte; P C Limburg Journal: J Rheumatol Date: 1994-03 Impact factor: 4.666
Authors: Peter K Schädlich; Henning Zeidler; Angela Zink; Erika Gromnica-Ihle; Matthias Schneider; Christoph Straub; Josef G Brecht; Eduard Huppertz Journal: Pharmacoeconomics Date: 2005 Impact factor: 4.981
Authors: X Le Loët; J M Berthelot; A Cantagrel; B Combe; M De Bandt; B Fautrel; R M Flipo; F Lioté; J F Maillefert; O Meyer; A Saraux; D Wendling; F Guillemin Journal: Ann Rheum Dis Date: 2005-06-30 Impact factor: 19.103
Authors: Linda Mary Davies; Emily Anne Fargher; Karen Tricker; Peter Dawes; David L Scott; Deborah Symmons Journal: Ann Rheum Dis Date: 2006-11-23 Impact factor: 19.103
Authors: E Wagner; K Ammer; G Kolarz; I Krajnc; E Palkonyai; O Scherak; C Schödl; F Singer; P Temesvari; A Wottawa Journal: Rheumatol Int Date: 2007-04-11 Impact factor: 2.631